These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 14511922)

  • 1. Conformational exposure: a new handle on prions.
    Brown DR
    Lancet; 2003 Sep; 362(9388):929-30. PubMed ID: 14511922
    [No Abstract]   [Full Text] [Related]  

  • 2. Probing for prions: recognizing misfolded PrP.
    Caughey B
    Nat Med; 2003 Jul; 9(7):819-20. PubMed ID: 12835691
    [No Abstract]   [Full Text] [Related]  

  • 3. An overview of the diagnostic tools.
    Coste J
    Transfus Clin Biol; 2013 Sep; 20(4):412-5. PubMed ID: 23928182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
    Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
    Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic prion protein is specifically recognized in situ by a novel PrP conformational antibody.
    Moroncini G; Mangieri M; Morbin M; Mazzoleni G; Ghetti B; Gabrielli A; Williamson RA; Giaccone G; Tagliavini F
    Neurobiol Dis; 2006 Sep; 23(3):717-24. PubMed ID: 16876426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prion protein epitope selective for the pathologically misfolded conformation.
    Paramithiotis E; Pinard M; Lawton T; LaBoissiere S; Leathers VL; Zou WQ; Estey LA; Lamontagne J; Lehto MT; Kondejewski LH; Francoeur GP; Papadopoulos M; Haghighat A; Spatz SJ; Head M; Will R; Ironside J; O'Rourke K; Tonelli Q; Ledebur HC; Chakrabartty A; Cashman NR
    Nat Med; 2003 Jul; 9(7):893-9. PubMed ID: 12778138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human prion diseases: from antibody screening to a standardized fast immunodiagnosis using automation.
    Privat N; Laffont-Proust I; Faucheux BA; Sazdovitch V; Frobert Y; Laplanche JL; Grassi J; Hauw JJ; Haïk S
    Mod Pathol; 2008 Feb; 21(2):140-9. PubMed ID: 18084251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chicken antibody against a restrictive epitope of prion protein distinguishes normal and abnormal prion proteins.
    Miyamoto K; Kimura S; Nakamura N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
    Biologicals; 2007 Oct; 35(4):303-8. PubMed ID: 17363268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunoassay for the pathological form of the prion protein based on denaturation and time resolved fluorometry.
    Dabaghian RH; Barnard G; McConnell I; Clewley JP
    J Virol Methods; 2006 Mar; 132(1-2):85-91. PubMed ID: 16219367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species-specificity of a panel of prion protein antibodies for the immunohistochemical study of animal and human prion diseases.
    Furuoka H; Yabuzoe A; Horiuchi M; Tagawa Y; Yokoyama T; Yamakawa Y; Shinagawa M; Sata T
    J Comp Pathol; 2007 Jan; 136(1):9-17. PubMed ID: 17270205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of possible animal origins of prion disease in human beings.
    Priola SA; Vorberg I
    Lancet; 2004 Jun; 363(9426):2013-4. PubMed ID: 15207949
    [No Abstract]   [Full Text] [Related]  

  • 12. Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc.
    Moroncini G; Kanu N; Solforosi L; Abalos G; Telling GC; Head M; Ironside J; Brockes JP; Burton DR; Williamson RA
    Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10404-9. PubMed ID: 15240877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eight prion strains have PrP(Sc) molecules with different conformations.
    Safar J; Wille H; Itri V; Groth D; Serban H; Torchia M; Cohen FE; Prusiner SB
    Nat Med; 1998 Oct; 4(10):1157-65. PubMed ID: 9771749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein conformation dictates prion strain.
    Aguzzi A
    Nat Med; 1998 Oct; 4(10):1125-6. PubMed ID: 9771742
    [No Abstract]   [Full Text] [Related]  

  • 15. Improved conformation-dependent immunoassay: suitability for human prion detection with enhanced sensitivity.
    Bellon A; Seyfert-Brandt W; Lang W; Baron H; Gröner A; Vey M
    J Gen Virol; 2003 Jul; 84(Pt 7):1921-1925. PubMed ID: 12810888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiaggregating antibody raised against human PrP 106-126 recognizes pathological and normal isoforms of the whole prion protein.
    Hanan E; Priola SA; Solomon B
    Cell Mol Neurobiol; 2001 Dec; 21(6):693-703. PubMed ID: 12043842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future uncertain for reliable vCJD screening tests.
    Bonn D
    Lancet; 2000 Jul; 356(9225):228. PubMed ID: 10963208
    [No Abstract]   [Full Text] [Related]  

  • 18. Current and future molecular diagnostics for prion diseases.
    Lehto MT; Peery HE; Cashman NR
    Expert Rev Mol Diagn; 2006 Jul; 6(4):597-611. PubMed ID: 16824033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reference materials for the evaluation of pre-mortem variant Creutzfeldt-Jakob disease diagnostic assays.
    Cooper JK; Ladhani K; Minor PD
    Vox Sang; 2007 May; 92(4):302-10. PubMed ID: 17456154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prions and proteins: distinguishing between conformations.
    Bolton DC
    Lancet; 2001 Jul; 358(9277):164-5. PubMed ID: 11476826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.